Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2026)
Incannex Healthcare (IXHL) posted Free Cash Flow of -$2.4 million for Q1 2026, up 46.87% sequentially from -$4.6 million in Q4 2025, and up 21.88% YoY from -$2.0 million in Q1 2025.
Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2026) Analysis & Trends
Incannex Healthcare has reported Free Cash Flow for 4 years, with the latest figure at -$2.4 million in Q1 2026.
- Quarterly Free Cash Flow rose 21.88% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.7 million (down 20.84% YoY) and the FY2025 annual result came in at -$12.5 million, up 22.34% from the prior year.
- Free Cash Flow rose to -$2.4 million in Q1 2026 per IXHL's latest filing, from -$4.6 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$1.5 million in Q2 2025 and troughed at -$9.2 million in Q3 2025.
- A 4-year average of -$3.9 million and a median of -$3.1 million in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow jumped 62.4% in 2024, then tumbled 309.89% in 2025.
- Over 4 years, Free Cash Flow stood at -$2.2 million in 2023, then tumbled by 161.56% to -$5.7 million in 2024, then grew by 18.59% to -$4.6 million in 2025, then soared by 46.87% to -$2.4 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$2.4 million, -$4.6 million, and -$9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Dec 31, 2025 | -4.60 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Mar 31, 2025 | -3.13 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Dec 31, 2024 | -5.66 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Jun 30, 2024 | -3.65 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Mar 31, 2024 | -4.35 Mn |
| Dec 31, 2023 | -2.16 Mn |
| Dec 31, 2023 | -2.16 Mn |